Position in IRD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,621,295
+$3,171,817 QoQ
Shares Held
1,367,712
+154.1% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 102 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. IRD ranks #228 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in IRD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,621,295 | 1,367,712 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,449,478 | 538,347 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,015,015 | 504,983 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $773,745 | 468,937 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $334,335 | 355,677 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $346,340 | 353,409 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $373,640 | 313,984 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $356,687 | 272,281 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $406,756 | 265,854 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $471,139 | 234,398 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $659,530 | 219,113 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $734,028 | 219,113 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $842,172 | 194,049 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $680,137 | 181,370 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $610,926 | 173,067 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $304,653 | 151,569 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $283,121 | 147,459 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $420,953 | 129,924 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $339,683 | 91,068 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $406,453 | 78,923 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $135,136 | 25,594 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $65,653 | 11,300 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||